Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Debt Ratio (2016 - 2021)

GT Biopharma (GTBP) has disclosed Debt Ratio for 12 consecutive years, with 0.01 as the latest value for Q3 2021.

  • On a quarterly basis, Debt Ratio fell 99.96% to 0.01 in Q3 2021 year-over-year; TTM through Sep 2021 was 0.01, a 99.96% decrease, with the full-year FY2020 number at 0.07, down 99.78% from a year prior.
  • Debt Ratio was 0.01 for Q3 2021 at GT Biopharma, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 45.04 in Q1 2020 to a low of 0.0 in Q3 2017.
  • A 5-year average of 9.86 and a median of 0.42 in 2019 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: crashed 100.0% in 2017, then soared 331317.64% in 2018.
  • GT Biopharma's Debt Ratio stood at 0.0 in 2017, then skyrocketed by 328537.31% to 0.4 in 2018, then surged by 8246.63% to 33.43 in 2019, then crashed by 99.78% to 0.07 in 2020, then crashed by 85.86% to 0.01 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Debt Ratio are 0.01 (Q3 2021), 0.02 (Q2 2021), and 0.01 (Q1 2021).